➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Merck
Mallinckrodt
Harvard Business School
Dow

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Litigation Details for Teijin Limited v. Prinston Pharmaceutical Inc. (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Teijin Limited v. Prinston Pharmaceutical Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Teijin Limited v. Prinston Pharmaceutical Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-07-01 1 for infringement of U.S. Patent No. 6,225,474 (“the ’474 patent” or “patent-in-suit”). This action arises…date of the ’520 patent is March 25, 2019. INFRINGEMENT OF U.S. PATENT NO. 6,225,474 28. Plaintiffs … the ’474 patent is attached as Exhibit A. ll. Teijin Ltd. is the owner of the ’474 patent. Teijin Pharma…certification with respect to U.S. Patent No. 5,614,520 (“the ’520 patent”) pursuant to 21 U.S.C. § 505@)…’474 patent, including any applicable exclusivities or extensions, would infringe the ’474 patent under External link to document
2015-10-15 37 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,372,872 B2; . (Noreika, Maryellen… 13 November 2015 1:14-cv-00854 830 Patent None District Court, D. Delaware External link to document
2014-07-01 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,225,474 B1. (etg) (Entered:… 13 November 2015 1:14-cv-00854 830 Patent None District Court, D. Delaware External link to document
2015-11-13 40 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,225,474 B1; 8,372,872 B2. (… 13 November 2015 1:14-cv-00854 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Harvard Business School
Medtronic
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.